-
The IPO comprises a fresh issue of equity share of the bank worth Rs 330 crore and an offer for sale aggregating up to Rs 1,000 crore by promoter Fincare Business Services
-
Market is expected to remain range-bound in the coming truncated week
-
Foreign investors had pulled out Rs 9,659 crore in April after infusing money in the preceding six months, according to the depositories' data
-
The index consists of 25 Covid-stocks broadly categorised into five verticals of the healthcare industry — vaccine manufacturers, pharma companies, hospital chains, pathology laboratories and medical equipment manufacturers
-
Investment by mutual funds in equities will continue in coming months seeing the increase in user growths as multiple fintech players are entering into this space, says an industry expert
-
The market valuation of TCS jumped Rs 34,623.12 crore to reach Rs 11,58,542.89 crore. Hindustan Unilever Ltd added Rs 13,897.69 crore to take its valuation to Rs 5,66,950.71 crore
-
Investors seem to have factored in the heightened daily COVID cases and are currently looking beyond the short-term impact, say analysts
-
The metal and pharma sectors are likely to continue their bull run whereas in the short term, BFSI, FMCG and auto sectors are likely to see some short-covering
-
The benchmark equity index BSE Sensex surged 424 points, or 0.87%, to 49,206 during the week.
-
Axis Securities has recommended over 10 stocks that can deliver robust returns to investors in the long run